The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

Targeted Therapy in Advanced GE/GEJ Cancer: T-DXd, mFOLFOX6+/-1L Bemarituzumab, Margetuximab, Rucaparib+Ramucirumab+/-Nivo

281 views
June 11, 2021
0 Comments
Login to view comments. Click here to Login
2021 KUMC Virtual Multidisciplinary Oncology Review